You can find more information about PF3D7_1347200-Nucleosides using the following links:

PlasmoDB - the Plasmodium genome resource
The TDR Targets Database

Subcellular Localization

Affecting Drugs
Drug Name PubMed Articles (year of publication)
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[2-[2-[2-(1-naphthyloxy)ethoxy]ethoxy]ethylamino]purin-9-yl]tetrahydrofuran-3,4-diol
2-[2-(2-methyphenyl)vinyl]-4(3H)-quinazoline
2-Hydroxy-7-methoxy-2-(1,1,2,2,2-pentafluoroethyl)-3H-chromen-4-one
3-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethylamino]-1,1-diphenyl-propan-2-one
4-(3a,7a-dihydro-1H-indol-3-yl)-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]butanamide
4-[benzyl(ethyl)amino]-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]-3-nitro-benzamide
4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one
Difference from host, suggested target
Kinetic characterization, suggested target
N(6)-substituted adenosine derivatives
N,N'-(benzo[d]thiazole-2,6-diyl)bis(furan-2-carboxamide)
N,N'-1,3-benzothiazole-2,6-diyldi(2-furamide)
N-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethyl]-4-oxo-4-(4-phenylphenyl)butanamide
N6-hydroxy-9H-purin-6-amine
N-Cyclopropyl-2-{[3-(2-oxo-1-pyrrolidinyl)benzoyl]amino}benzamide
Plasmodium specific phosphatases, suggested target